Send me a link:

*Text messaging rates may apply.

 Dow Down 0.02% Nasdaq Down 0.04%

More On SPHS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Sophiris Bio, Inc. (SPHS)

-NasdaqGM
2.43 0.10(3.96%) Jul 24, 3:54PM EDT
Prev Close:2.53
Open:2.50
Bid:1.60 x 200
Ask:3.28 x 1000
1y Target Est:8.63
Beta:0.79
Next Earnings Date:N/A
Day's Range:2.36 - 2.50
52wk Range:2.10 - 14.56
Volume:30,841
Avg Vol (3m):47,883
Market Cap:39.24M
P/E (ttm):N/A
EPS (ttm):-1.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SPHS

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.65
Quarterly EPS Est (Jun-14) :-0.46
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of products for the treatment of urological diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback